Logo Future Medicine Science Match

Program "Future Medicine"

Every speaker has exactly 3 minutes to present his work!

Please note: minor changes to the program are still possible. (Last update: 02.11.2016)

You can download the program here.

08:30 Entrance  

09:30 Welcome: Sebastian Turner, Publisher, Der Tagesspiegel

           Welcome: Prof. Erwin Böttinger, CEO, Berlin Institute of Health (BIH)

           Opening: Prof. Helge Braun, Minister of State to the Federal Chancellor

09:50 Session 1: Personalized Health

Keynote: Prof. Ernst Hafen, ETH Zürich
Genome Meets iPhone – Transforming Health Science by Citizen-Controlled Data Access

10:05 Short Presentations:

Dr. Roland Schwarz, Max Delbrück Center for Molecular Medicine (MDC)
The Effect of Somatic Variation on the Regulatory Landscape – a Pan-Cancer Perspective

Dr. Ute Scholl, Heinrich-Heine-Universität Düsseldorf
Hypertension – from Disease to Discovery

Dr. Michela Serresi, Max Delbrück Center for Molecular Medicine (MDC)
Molecular Mechanisms Underlying Lung Cancer Dissemination to the Brain

Eimear Kenny, Ph.D., Icahn School of Medicine at Mount Sinai, New York City
Biogeography – a New Biomarker for Personalized Medicine 

Dr. Jana Striefler, Charité – Universitätsmedizin Berlin
Pancreatic Cancer – the Feared Opponent

Dr. Annika Fendler, Max Delbrück Center for Molecular Medicine (MDC), Berlin Institute of Health (BIH)
Combined Inhibition of WNT and NOTCH Signaling as a Therapeutic Strategy for Human Clear Cell Kidney Carcinoma

Dr. Daniel IbrahimMax Planck Institute for Molecular Genetics (MPIMG)
Disruption of 3D Genome Architecture by Structural Variations

Lili Milani, Ph.D., Estonian Genome Center, Tartu
Possibilities for Nation-Wide Implementation of Genomic Medicine 

Dr. Antigoni Triantafyllopoulou, University of Freiburg
Harnessing DNA Damage to Re-Program Macrophages in Granulomatous Diseases

Dr. Tanja Schmitz-Hübsch, Charité – Universitätsmedizin Berlin
Digital Health Outcomes as a Decision Aid Towards Patient-Centered Care  

Ashley Eheim, Bayer Pharma AG, Berlin
Epigenetic Modifiers & The Human Condition

Dr. Carl Weidinger, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
Targeting Calcium Influx in Chronic Inflammatory Bowel Disease

Dr. Elke Dworatzek, Charité – Universitätsmedizin Berlin
Sex Matters: Development of Cardiac Fibrosis Differs between Men and Women

Dr. Charlotte Christine Kopitz, Bayer Pharma AG, Berlin
Anetumab Ravtansine - A Novel Antibody-Drug Conjugate for the Treatment of Mesothelin-Positive Tumors

Dr. Hedwig Deubzer, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
Personalized Medicine in Pediatric Oncology

Dr. Josefine Radke, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
Molecular Genetic Analysis of CNS Lymphoma 

Dr. Markus Koch, Bayer Pharma AG, Berlin
Addressing Neglected Diseases: Innovative Ways to Relieve Women from the Burden of Endometriosis

Dr. Claudia Brockmann, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
Animal Models to Investigate Retinal Vascular Diseases

Dr. Dorothea Rat, Sanofi Aventis Deutschland GmbH
Patient Stratification in Cystic Fibrosis

Dr. Mir-Farzin MashreghiGerman Rheumatism Research Centre Berlin (DRFZ)
Therapeutic Oligonucleotides as Novel Therapy for Autoimmune Diseases

11:05 Matching Break 

11:50 Session 2: Digital Health

Session Introduction: Morris Hosseini, Ph.D., Roland Berger, Competence Center Pharma & Healthcare, Berlin

Keynote: Dr. Shari Langemak, Medscape Germany, Berlin
The Future is Already Here: Digital Innovations that Will Change Healthcare Forever 

12:10 Short Presentations:

Dexter Hadley, MD Ph.D., UCSF School of Medicine, San Francisco
Translating Big Data Into Precision Screening and Diagnosis of Melanoma with Smartphones

Alexander Puschilov, viomedo UG, Berlin
Accelerating Time to Market: Providing Patients with Access to Clinical Trials

Dr. Johannes Starlinger, Humboldt-Universität zu Berlin
Simpatix: Similarity Search for Richly Annotated Structured Patient Cases

Dr. Petra Ritter, Charité – Universitätsmedizin Berlin
Bridging Multiple Scales in the Human Brain Using Personalized Computational Modelling

Dr. Sebastian Köhler, Charité – Universitätsmedizin Berlin
Phenotype-Driven Analysis of Genomic Variation

Oren MironHarvard Medical School, Boston
Autism Detection at Birth

Dr. Madeleine Kittner, Humboldt-Universität zu Berlin
How Data Integration and Text Mining Can Support Personalized Cancer Therapy

Dr. Birte Kehr, Berlin Institute of Health (BIH)
Genomic Structural Variants in Disease

Dr. Paul Jahnke, Charité – Universitätsmedizin Berlin
PhantomX – Patient Individual Phantoms for Computed Tomography and Radiation Therapy

Paul ChojeckiFraunhofer Heinrich Hertz Institute (HHI), Berlin
The Next Big Thing in Medical Interfaces – Monitors with Brains, Eyes and Ears

Prof. Alice McHardyHelmholtz Centre for Infection Research (HZI), Braunschweig
Computational Inference of Microbial Genotype-Phenotype Relationships 

Dr. Maria Lorena Dini Pou del Castillo, Charité – Universitätsmedizin Berlin
Kolegea Web 2.0 Plattform – Connecting General Practice 

Prof. Carsten Finke, Charité – Universitätsmedizin Berlin
Digital Diagnosis and Treatment of Cognitive Deficits 

Christian Wesemann, Charité – Universitätsmedizin Berlin
Wearable Technologies for Improved Patient Compliance in Orthodontic Treatment – Development of Intelligent Micro Sensor Foils by Using Organic and Printed Electronics

Dr. Alessandro Blasimme, University of Zurich
Health, Data and the Digital Self: Philosophy at the Dawn of New Medicine

Carolin Reimann, Charité – Universitätsmedizin Berlin
Molecular MR Imaging in Vascular Diseases to Improve Early Diagnosis

Dr. Christian ConradGerman Cancer Research Center (DKFZ), Heidelberg
Intelligent Imaging and Sequencing

13:10 Lunch 

14:35 Session 3: Start-Up Ecosystems

Keynote: Adrian J. Carter, Ph.D.Boehringer Ingelheim Pharma GmbH
Harnessing the Creative Power of the Scientific Crowd

14:50 Short Presentations:

Dr. Klaus StöckemannPeppermint VenturePartners
Hypes and Hopes around Digital Health 

Dr. Klaus Nitschke, Senior Advisor Digital - Investor
Embracing the Future – How to Successfully Build Digital Businesses in Health

Dr. Christian Jung, Wellington Partners Venture Capital, Munich
The Current State of Life Science Venture Investing

Dr. Simone Schürle, Massachusetts Institute of Technology (MIT)
Magnetically Actuated Protease Sensors for Precision Diagnostics 

Dr. Jens Peter von Kries, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin
Finding the Needle in the Haystack. Particular Requirements for High-Throughput Experiments (Chemical Biology Core Facility)

Prof. Thoralf Niendorf, Max Delbrück Center for Molecular Medicine (MDC) & MRI.TOOLS GmbH, Berlin
Heartware and More: Bridging the Gap in Translational Medicine with Magnetic Resonance Imaging  

Prof. Craig Garner, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)
Enhancing Academic Transaltion 

Juliane Müllerdiafyt MedTech, Leipzig
On the Path to the Optimal Amount of Insulin for Diabetics 

Omar F. Khan, Ph.D., Massachusetts Institute of Technology (MIT)
Customizable, Rapid-Response Vaccine Platform Technology 

Dr. Philipp Mergenthaler, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
Machine Learning for Personalized Immunotherapy in Rare Neurological Autoimmune Disease

Tobias Meixner, smartHELIOS and helios.hub, HELIOS Kliniken GmbH
How We Evaluate Digitial Innovations and Scale Them Up

Dr. Markus DahlemNewsenselab GmbH, Berlin
Personalized, Data-Driven Migraine Therapy 

Prof. Matthias Taupitz, Charité – Universitätsmedizin Berlin
Important Hurdles in the Development of Nanotechnology Based Drugs 

Dr. Thomas Wilckens, InnVentis Ltd.
From Big Data to Precision Medicine – Challenges = Opportunities?!

Juliane ZielonkaStartupbootcamp Digital Health Berlin
Building a Digital Health Ecosystem for Start-Ups in Co-Creation with Corporates 

15:30 Matching Break 

16:00 Session 4: Regenerative Medicine

Keynote: Prof. Hans-Dieter Volk, Charité – Universitätsmedizin Berlin
Immune Reactivity – Friend or Foe of Regeneration

16:15 Short Presentations:

Dr. Bernd Hewing, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
Targeting Inflammatory Pathways for the Treatment of Atherosclerosis 

Dr. Annette Künkele, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
A CAR‑T Cell Approach for Solid Tumor Attack

Dr. Il-Kang Na, Charité – Universitätsmedizin Berlin
Restore the Bone Marrow Niche and Immune Competence After Allogeneic Hematopoietic Stem Cell Transplantation

Dr. Mina Gouti, Max Delbrück Center for Molecular Medicine (MDC)
Neuromesodermal Progenitors: Tracing the Origins of Neuromuscular Diseases

Dr. Benjamin Strücker, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
Generation of a Tissue-Engineered Neo-Pancreas

Prof. Wolfram Zimmermann, Universitätsmedizin Göttingen
Tissue-Engineered Heart Repair 

Dr. Simon Reinke, Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
Immune Experience – Too Much of a Beautiful Thing within the Fracture Healing Process!

Prof. Andrew J. MurphyBaker Institute University of Melbourne
Controlling Haematopoiesis to Treat Cardiovascular Disease

Dr. Katja ThomasUniversitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Selective Immune Cell Characteristics in MS Pathology and its Relevance and Patient Individualized Treatment Strategies

Dr. Friederike Schröter, Heinrich-Heine-Universität Düsseldorf
Study Alzheimers' Diseased Neurons in a Dish

Dr. Sybille Landwehr-Kenzel, Charité – Universitätsmedizin Berlin
Reshaping Undesired Adaptive Immunity by nTreg Therapy 

Dr. Alexander Paliege, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
Annexins as Protective Mediators in Renal Disease

Dr. Sara Checa EstebanJulius Wolff Institute, Berlin
Using Computer Models to Promote Skeletal Regeneration

Matthias Obenaus, Charité – Universitätsmedizin Berlin, Berlin Institute of Health (BIH)
T Cell Receptor Gene Therapy of Cancer

Dr. Ana Textor, Charité – Universitätsmedizin Berlin, Max Delbrück Center for Molecular Medicine (MDC)
Refining the Targets for T Cell Receptor Gene Therapy

Dr. Soeren Lienkamp, University of Freiburg
Direct Reprogramming of Fibroblasts to Renal Tubule Cells

Dr. Jan Philipp Junker, Max Delbrück Center for Molecular Medicine (MDC)
Understanding Tissue Regeneration on the Single Cell Level

17:05 Session 5: Cell Engineering

Keynote: Ross Cagan, Ph.D., Icahn School of Medicine at Mount Sinai, New York City
Fly to Bedside

17:20 Short Presentations:

Dr. Felix Lorenz, Max Delbrück Center for Molecular Medicine (MDC)
Next Generation T Cell Receptors for Cancer Immunotherapy

Pietro Genovese, Ph.D.The San Raffaele Telethon Institute for Gene Therapy, Milan
Toward Clinical Translation of Haematopoietic Stem Cell Gene Editing for the Treatment of Inherited Diseases 

Dr. Gaetano Gargiulo, Max Delbrück Center for Molecular Medicine (MDC)
Glioblastoma Subtype Avatar models for Target Discovery and Biology

Dr. Sebastiaan van Heesch, Max Delbrück Center for Molecular Medicine (MDC)
Think Small! New Proteins in Heart Disease

Dr. Michael Schmück-HenneresseCharité – Universitätsmedizin Berlin
Adoptive Cellular Immunotherapy for Viral Diseases

Dr. Barbara Di Ventura, Heidelberg University 
Synthetic Biology Approaches for Less Invasive, Versatile and Sustainable Treatments

Dr. Scott Allen Lacadie, Max Delbrück Center for Molecular Medicine (MDC)
Shedding Light on Genomic 'Dark Matter'– Associated Disease Using Zebrafish Embryonic Development

Dr. Carsten Corvey, Sanofi Aventis Deutschland GmbH
Multispecific Protein Therapeutics for Targeted Therapies

Annelie Blumrich, German Center for Cardiovascular Research (DZHK), Berlin
The Fruit Fly – An Appropriate Model to Study Heart Function?

Andreas Ofenbauer, Max Delbrück Center for Molecular Medicine (MDC)
Gene Activation With CRISPR/Cas Featuring Breakdancing Worms

Prof. Georgios Kararigas, Charité – Universitätsmedizin Berlin
En Route for Personalized Health through the Integration of Sex/Gender Based Science

18:05 Farewell: Sebastian Turner, Publisher, Der Tagesspiegel

           Farewell: Prof. Erwin Böttinger, CEO, Berlin Institute of Health (BIH)

18:15 Get Together